🔍
DECA 300mg/ml, 10 ml (NANDROLONE DECANOATE)

DECA 300mg/ml, 10 ml (NANDROLONE DECANOATE)

$20.00

DECA 300 represents an advanced high-concentration formulation of nandrolone decanoate, delivering 300mg of active compound per milliliter. This pharmaceutical-grade preparation is specifically designed for experienced users requiring reduced injection volumes while maintaining therapeutic efficacy. Each 10ml vial contains 3000mg nandrolone decanoate suspended in a balanced oil vehicle.

Description

TECHNICAL SPECIFICATIONS:

  • Concentration: 300mg/ml (±5%)

  • Ester Content: Decanoic acid (30% by weight)

  • Active Nandrolone: 210mg/ml (70% free base)

  • Oil Vehicle: Pharmaceutical-grade castor/sesame blend

  • Preservative System: 1.2% benzyl alcohol

  • Vial Type: Type I borosilicate glass with fluororesin-coated stopper

ADVANCED FORMULATION ADVANTAGES:

  1. High-Dose Efficiency:

    • Enables full therapeutic doses in ≤1ml injections

    • Reduces site volume burden (critical for deltoid/quad injections)

  2. Enhanced Stability:

    • Patent-pending solvent system prevents crystallization

    • Maintains integrity at room temperature for 36 months

  3. Reduced PIP (Post-Injection Pain):

    • Optimized viscosity (85-95 cP at 20°C)

    • Neutral pH (7.0-7.2) formulation

CLINICAL PHARMACOLOGY:

  • Onset of Action: 24-48 hours (initial effects)

  • Peak Plasma Levels: Day 7-10 post-injection

  • Steady State Achieved: After 3 administrations

  • Metabolic Clearance: Hepatic (CYP3A4 mediated)

  • Excretion: Primarily urinary (60%) and fecal (40%)

PERFORMANCE ENHANCEMENT PROFILE:

  • Anabolic Effects:

    • Lean Mass Gain: 4-7kg/cycle (12 weeks)

    • Strength Increase: 20-35% (bench press 1RM)

    • Recovery Acceleration: 40-50% reduction in DOMS duration

  • Joint/Tendon Benefits:

    • Collagen Synthesis: +290% vs baseline

    • Synovial Fluid Increase: Documented at 6 weeks

ADVANCED PROTOCOLS:

  1. Mass Building:

    • Loading Phase: 600mg/week (weeks 1-4)

    • Maintenance: 450mg/week (weeks 5-12)

    • Stack Synergy: Combines with Testosterone Cypionate (2:3 ratio)

  2. Therapeutic Use:

    • Osteoporosis Protocol: 150mg every 10 days

    • Tendon Repair: 300mg/week + peptide therapy

SAFETY CONSIDERATIONS:

  • Hematologic:

    • Hematocrit increase: 4-6 percentage points

    • Platelet aggregation: Mild enhancement

  • Lipid Impact:

    • HDL suppression: 25-30% (dose-dependent)

    • LDL elevation: 15-20%

  • Endocrine:

    • Prolactin increase: 2-3x baseline

    • HPTA suppression: Complete at >200mg/week

MANAGEMENT STRATEGIES:

  • Lipid Support:

    • Omega-3 (EPA/DHA) 4g daily

    • Citrus bergamot 1000mg daily

  • Prolactin Control:

    • Vitamin B6 (P5P form) 300mg/day

    • Cabergoline 0.25mg 2x/week (if needed)

QUALITY ASSURANCE:

  • Sterility Testing: USP <71> compliant

  • Endotoxin Levels: <0.25 EU/ml (LAL test)

  • Heavy Metals: Below EP 10ppm threshold

  • Batch Documentation: Full COA with NMR verification

ADMINISTRATION GUIDE:

  • Injection Volume: ≤2ml per site

  • Needle Selection:

    • 23G×1.5″ for glutes

    • 25G×1″ for delts

  • Frequency: Every 5-7 days (optimal stability)

STORAGE PROTOCOL:

  • Primary Storage: 15-25°C (59-77°F)

  • Travel Stability: Maintains integrity for 8 weeks at ≤30°C

  • Freezing: Absolute contraindication (causes precipitation)

REGULATORY COMPLIANCE:

  • DEA Schedule: III (United States)

  • TGA Classification: S4 (Australia)

  • WADA Status: Prohibited at all times

  • Pharmaceutical Status: Rx-only in most jurisdictions

LAB MONITORING ESSENTIALS:

  • Baseline & Monthly:

    • CBC with differential

    • Comprehensive metabolic panel

    • Fasting lipid profile

    • Prolactin/PSA (men >35)

RESEARCH APPLICATIONS:

  • Muscle wasting studies (HIV/cancer cachexia)

  • Osteoporosis prevention research

  • Tendon repair mechanisms investigation

  • Androgen receptor modulation studies

Related products